Clinical Trials
25 trialsNCT07586826 2026-05-14
N01-A-PICIT-GT
Peking University People's Hospital
Phase 2 Recruiting
NCT06950697 2026-04-30
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Beijing Chao Yang Hospital
Recruiting
NCT07439991 2026-02-27
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
The First Hospital of Jilin University
Recruiting
NCT06314763 2024-04-30
ROSIE
Radboud University Medical Center
Phase 4 Completed
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT00310232 2024-04-02
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Terminated
NCT06143735 2023-11-22
A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT04939558 2023-06-02
CARES
TidalSense
Completed
NCT00858364 2022-11-30
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Amgen
Phase 3 Terminated
NCT03090880 2022-11-17
PROVE
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT03776032 2018-12-20
A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
Amgen
Phase 3 Completed
NCT02334007 2018-09-18
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
Phase 1/2 Completed
NCT03581708 2018-07-10
RIVAL
Guangdong Provincial People's Hospital
Unknown
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT01813721 2017-03-15
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Amgen
Completed
NCT00003600 2016-07-13
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00077311 2016-06-30
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT01267305 2014-04-29
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
Shanghai Zhongshan Hospital
Phase NA Completed
NCT00413283 2013-10-24
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Amgen
Phase 2 Completed
NCT00072059 2013-07-18
Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00192829 2007-04-11
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
Rambam Health Care Campus
Unknown